Annual SGA
$36.49 M
+$3.59 M+10.90%
December 31, 2023
Summary
- As of March 1, 2025, FDMT annual SGA is $36.49 million, with the most recent change of +$3.59 million (+10.90%) on December 31, 2023.
- During the last 3 years, FDMT annual SGA has risen by +$19.26 million (+111.71%).
- FDMT annual SGA is now at all-time high.
Performance
FDMT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$12.65 M
+$2.05 M+19.34%
September 30, 2024
Summary
- As of March 1, 2025, FDMT quarterly SGA is $12.65 million, with the most recent change of +$2.05 million (+19.34%) on September 30, 2024.
- Over the past year, FDMT quarterly SGA has increased by +$3.54 million (+38.84%).
- FDMT quarterly SGA is now at all-time high.
Performance
FDMT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.87 B
-$143.48 M-8.30%
September 30, 2024
Summary
- As of March 1, 2025, FDMT TTM SGA is -$1.87 billion, with the most recent change of -$143.48 million (-8.30%) on September 30, 2024.
- Over the past year, FDMT TTM SGA has dropped by -$1.91 billion (-5548.64%).
- FDMT TTM SGA is now -6135.46% below its all-time high of -$30.03 million.
Performance
FDMT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
FDMT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.9% | +38.8% | -5548.6% |
| 3 y3 years | +111.7% | +38.8% | -5548.6% |
| 5 y5 years | +491.8% | +38.8% | -5548.6% |
FDMT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.3% | at high | +72.6% | -167.2% | at low |
| 5 y | 5-year | at high | +162.6% | at high | +313.2% | -1394.7% | at low |
| alltime | all time | at high | +946.0% | at high | +314.5% | -6135.5% | at low |
4D Molecular Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $12.65 M(+19.3%) | $44.15 M(+8.7%) |
| Jun 2024 | - | $10.60 M(+3.0%) | $40.61 M(+4.7%) |
| Mar 2024 | - | $10.29 M(-2.9%) | $38.80 M(+6.3%) |
| Dec 2023 | $36.49 M(+10.9%) | $10.61 M(+16.4%) | $36.50 M(+6.2%) |
| Sep 2023 | - | $9.11 M(+3.7%) | $34.36 M(+3.2%) |
| Jun 2023 | - | $8.79 M(+10.0%) | $33.30 M(+1.9%) |
| Mar 2023 | - | $7.99 M(-5.6%) | $32.68 M(-0.7%) |
| Dec 2022 | $32.91 M(+17.5%) | $8.47 M(+5.1%) | $32.92 M(+3.6%) |
| Sep 2022 | - | $8.05 M(-1.4%) | $31.78 M(-0.4%) |
| Jun 2022 | - | $8.17 M(-0.8%) | $31.91 M(+4.0%) |
| Mar 2022 | - | $8.23 M(+12.3%) | $30.70 M(+9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $28.01 M(+62.5%) | $7.33 M(-10.5%) | $28.01 M(+1.8%) |
| Sep 2021 | - | $8.19 M(+17.7%) | $27.52 M(+19.6%) |
| Jun 2021 | - | $6.95 M(+25.4%) | $23.02 M(+20.3%) |
| Mar 2021 | - | $5.54 M(-19.0%) | $19.13 M(+11.0%) |
| Dec 2020 | $17.24 M(+24.1%) | $6.84 M(+85.8%) | $17.24 M(+5.4%) |
| Sep 2020 | - | $3.68 M(+20.2%) | $16.36 M(+4.0%) |
| Jun 2020 | - | $3.06 M(-16.2%) | $15.73 M(+24.2%) |
| Mar 2020 | - | $3.65 M(-38.7%) | $12.66 M(+40.6%) |
| Dec 2019 | $13.89 M(+125.3%) | $5.96 M(+95.2%) | $9.01 M(+195.2%) |
| Sep 2019 | - | $3.05 M | $3.05 M |
| Dec 2018 | $6.17 M(+76.8%) | - | - |
| Dec 2017 | $3.49 M | - | - |
FAQ
- What is 4D Molecular Therapeutics annual SGA?
- What is the all time high annual SGA for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual SGA year-on-year change?
- What is 4D Molecular Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly SGA year-on-year change?
- What is 4D Molecular Therapeutics TTM SGA?
- What is the all time high TTM SGA for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics TTM SGA year-on-year change?
What is 4D Molecular Therapeutics annual SGA?
The current annual SGA of FDMT is $36.49 M
What is the all time high annual SGA for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual SGA is $36.49 M
What is 4D Molecular Therapeutics annual SGA year-on-year change?
Over the past year, FDMT annual SGA has changed by +$3.59 M (+10.90%)
What is 4D Molecular Therapeutics quarterly SGA?
The current quarterly SGA of FDMT is $12.65 M
What is the all time high quarterly SGA for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly SGA is $12.65 M
What is 4D Molecular Therapeutics quarterly SGA year-on-year change?
Over the past year, FDMT quarterly SGA has changed by +$3.54 M (+38.84%)
What is 4D Molecular Therapeutics TTM SGA?
The current TTM SGA of FDMT is -$1.87 B
What is the all time high TTM SGA for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high TTM SGA is -$30.03 M
What is 4D Molecular Therapeutics TTM SGA year-on-year change?
Over the past year, FDMT TTM SGA has changed by -$1.91 B (-5548.64%)